Filter Results :

Your search for Drug Pipeline Analysis returned 3 reports

Sort by


Global Alzheimer's Disease Drugs Market, Regional Analysis & Forecast, Major Deals & Funding, and Pipeline Drugs Analysis to 2021

04 Jul 2017  |  Published by:  iGATE Research
Alzheimerís disease is the most common cause of dementia among older people. It is a devastating condition for those afflicted as well as their family members and caregivers; the situation is only getting worse as the population ages. With the ageing global population, the number of patients sufferi...

$ 1,250.00

Read More

Renal Cell Carcinoma - Global Drugs Market Forecast and Pipeline Analysis to 2021

16 May 2016  |  Published by:  iGATE Research
Renal cell carcinoma is the most common type of kidney cancer in adults. It accounts for approximately 3% of adult malignancies and 90-95% of neoplasms arising from the kidney. The global renal cell carcinoma drugs market is anticipated to cross US$ 4.3 Billion mark by 2021. There are many fac...

$ 1,190.00

Read More

Antibody-Drug Conjugates 2016: Perspectives & Opportunities - a Pipeline, Technology, Stakeholder & Business Analysis

30 Nov 2015  |  Published by:  La Merie Business Intelligence
This report describes and analyzes the situation of antibody-drug conjugates as of November 2015 regarding- ADC pipeline,- ADC technologies,- ADC stakeholders and- ADC business opportunities and commercial perspectives.Although the initial enthusiasm about antibody-drug conjugates has made room for ...

$ 2,778.43

Read More
Total 3 records.